SKAN Group AG/Fr. SKAN

1D1W1MYTD1Y5YMAX

About SKAN Group AG

SKAN Group AG is engaged in the design and manufacture of advanced cleanroom equipment and solutions, primarily servicing the pharmaceutical and biotechnology industries. It specializes in the development of isolator technology used for aseptic production processes, providing critical equipment that ensures sterile manufacturing environments. Founded in 1968, SKAN is headquartered in Allschwil, Switzerland, and has established a strong presence across the global market, including locations in North America, Europe, and Asia. The company's strategic focus lies in its expertise in containment solutions and decontamination processes, which positions it as a key player in supporting its clients’ compliance with stringent safety and quality regulations. SKAN's innovative approach and specialized knowledge have made its products integral to various high-tech pharmaceutical production lines.
Ticker
Fr. SKAN
Sector
Health
Primary listing
XSWX
Employees
1,694
Headquarters
Allschwil, Switzerland

SKAN Group AG Metrics

BasicAdvanced
CHF 1.4B
46.64
CHF 1.33
0.73
CHF 0.22
0.18%

Bulls say / Bears say

Order intake increased 16.3% to CHF 247.6 million and net sales rose 22.2% in H1 2026, confirming robust demand momentum and underpinning full-year guidance. (SKAN IR)
Order backlog grew 27.8% to CHF 442.3 million at 30 June 2026, providing strong revenue visibility. (SKAN IR)
Successful conversion of numerous engineering contracts won in 2025 into complete system orders in H1 2026 evidences efficient project pipeline execution. (SKAN IR)
Preliminary net sales for 2025 of around CHF 332 million represent an 8.2% decrease from CHF 361.3 million in 2024, highlighting revenue volatility. (SKAN IR)
Preliminary 2025 EBITDA of around CHF 38 million versus CHF 57.0 million in 2024 signals a 33% contraction in earnings and margin pressure. (SKAN IR)
Operating cash flow in H1 2026 fell 27.7% to CHF 16.3 million from CHF 22.6 million, potentially constraining free cash flow for reinvestment. (SKAN IR)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2026.

Funds containing SKAN Group AG

AllEURGBPUSD
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.